Stella Diagnostics (Stella Diagnostics) Debt-to-Asset : 3.28 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Debt-to-Asset?

Stella Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.65 Mil. Stella Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.80 Mil. Stella Diagnostics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2023 was $0.44 Mil. Stella Diagnostics's debt to asset for the quarter that ended in Sep. 2023 was 3.28.

Stella Diagnostics Debt-to-Asset Historical Data

The historical data trend for Stella Diagnostics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Debt-to-Asset Chart

Stella Diagnostics Annual Data

Trend

Debt-to-Asset

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Debt-to-Asset	-	3.28

Competitive Comparison of Stella Diagnostics's Debt-to-Asset

For the Diagnostics & Research subindustry, Stella Diagnostics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's Debt-to-Asset falls into.

Stella Diagnostics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Stella Diagnostics's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(	+	)	/
	=	N/A

Stella Diagnostics's Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.648	+	0.798)	/	0.441
	=	3.28

Stella Diagnostics (OTCPK:SLDX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Stella Diagnostics Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.